Posted in | News | Business | Chemistry

Air Liquide to Acquire OXEA’s Syngas Plant in Germany

In Germany, Air Liquide has just signed an agreement with OXEA GmbH for the acquisition of its syngas plant based in Oberhausen (Rhine-Ruhr area). Anti-trust authorities have given their approval.

This large plant has a production capacity of approximately 83,000 Nm³ per hour of syngas - a mixture of hydrogen and carbon monoxide - used in the production of oxo-intermediates and oxo-derivatives, which are used in high-quality coatings, lubricants and cosmetic and pharmaceutical products.

In close proximity to this syngas facility, Air Liquide is already operating three air separation units that have also delivered oxygen to OXEA for several years now. Air Liquide is currently building a fourth air separation unit in Oberhausen, with a production capacity of 2,400 tonnes of oxygen per day (as announced on June 5, 2008).

Guy Salzgeber, a member of Air Liquide’s Executive Committee, Vice-President for North and Central Europe, said: ”We are very glad to welcome the new employees from the OXEA plant to the Air Liquide Group. This takeover offers a good illustration of our growth strategy in existing large marketplaces and meets the increasing customer demand for the outsourcing of industrial gases activities. It will generate immediate revenue and intensify our longstanding relationship of cooperation with OXEA. Through this acquisition, Air Liquide reinforces its development in Germany and strengthens its position in the Rhine-Ruhr, one of the largest and leading industrial areas in Europe.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.